SOUTH SAN FRANCISCO, CA, Zenflow, a medical device company, has closed a $24 million Series C financing round.
Zenflow, a medical device company developing a minimally invasive treatment for urinary obstruction caused by enlarged prostate, or benign prostatic hyperplasia (BPH), announced that it has closed a $24 million Series C financing round. The round includes new investor Cook Medical as well as existing investors Invus Opportunities, F-Prime Capital, Medical Technology Venture Partners and others.
(c) by Massinvestor, Inc. For contact info, please check out our about page.
By VC News Daily
Source: VC News Daily
Discover more from FundingBlogger
Subscribe to get the latest posts sent to your email.